|
Market Closed -
Other stock markets
|
After hours 17:55:32 | |||
| 27.00 EUR | +4.49% |
|
27.01 | +0.04% |
| 02-16 | CARL ZEISS MEDITEC AG : Deutsche Bank sticks Neutral | ZD |
| 02-16 | CARL ZEISS MEDITEC AG : Bernstein reiterates its Neutral rating | ZD |
Business description: Carl Zeiss Meditec AG
Number of employees: 5,784
Sales by Activity: Carl Zeiss Meditec AG
| Fiscal Period: September | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Ophthalmic Devices (Including Surgical Ophthalmology) | 1.26B | 1.47B | 1.58B | 1.59B | 1.72B |
Microsurgery | 391M | 434M | 513M | 477M | 504M |
Geographical breakdown of sales: Carl Zeiss Meditec AG
| Fiscal Period: September | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Germany | 939M | 1.16B | 1.27B | 1.23B | 1.29B |
North America | - | - | 568M | 522M | 553M |
Europe (Without Germany) | 130M | 132M | 156M | 226M | 294M |
Asia | 101M | 103M | 99.68M | 83.33M | 86.07M |
United States of America | 477M | 513M | - | - | - |
Executive Committee: Carl Zeiss Meditec AG
| Manager | Title | Age | Since |
|---|---|---|---|
Andreas Pecher
CEO | Chief Executive Officer | 54 | 31/12/2025 |
| Director of Finance/CFO | 60 | 30/09/2018 | |
| Chief Operating Officer | 47 | - | |
| Investor Relations Contact | - | 31/08/2013 |
Composition of the Board of Directors: Carl Zeiss Meditec AG
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 09/04/2018 | |
Karl Lamprecht
CHM | Chairman | 62 | 26/05/2021 |
Isabel de Paoli
BRD | Director/Board Member | 52 | 24/06/2020 |
Rene Denner
BRD | Director/Board Member | 46 | 31/12/2018 |
Jeffrey Marx
BRD | Director/Board Member | 40 | 05/03/2020 |
Peter Kameritsch
BRD | Director/Board Member | 57 | 26/05/2021 |
Torsten Reitze
BRD | Director/Board Member | 49 | 26/05/2021 |
| Director/Board Member | 60 | 29/03/2022 | |
Falk Bindheim
BRD | Director/Board Member | - | 21/03/2023 |
Heike Madan
BRD | Director/Board Member | 54 | 21/03/2023 |
Holdings: Carl Zeiss Meditec AG
| Name | Equities | % | Valuation |
|---|---|---|---|
CARL ZEISS MEDITEC AG 2.13% | 1,904,491 | 2.13% | 63 M $ |
Company details: Carl Zeiss Meditec AG
Group companies: Carl Zeiss Meditec AG
| Name | Category and Sector |
|---|---|
Carl Zeiss Meditec Co., Ltd.
 Carl Zeiss Meditec Co., Ltd. Medical DistributorsDistribution Services Wholesales medical equipment |
Medical Distributors
|
HYALTECH Ltd.
 HYALTECH Ltd. BiotechnologyHealth Technology Develops and manufactures medical solutions |
Biotechnology
|
Carl Zeiss Meditec, Inc.
 Carl Zeiss Meditec, Inc. Medical SpecialtiesHealth Technology Develops glaucoma diagnosis products |
Medical Specialties
|
Other Advanced Medical Equipment & Technology
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.49% | -4.26% | -51.00% | -79.78% | 2.68B | |
| -0.57% | -6.84% | -3.87% | -10.16% | 190B | |
| +0.97% | -1.02% | -18.44% | +105.14% | 173B | |
| -2.99% | -5.85% | +1.16% | -19.27% | 150B | |
| +1.08% | +1.99% | -28.12% | +62.71% | 111B | |
| -0.24% | -0.07% | -28.89% | -18.86% | 54.13B | |
| +3.89% | +2.40% | +4.27% | +0.50% | 44.03B | |
| +1.53% | -2.66% | +11.25% | +18.68% | 36.79B | |
| +1.71% | +3.19% | -11.78% | +11.73% | 36.61B | |
| -1.88% | -4.12% | -8.51% | -16.57% | 35.58B | |
| Average | +0.78% | -3.23% | -13.39% | +5.41% | 83.31B | |
| Weighted average by Cap. | -0.12% | -2.94% | -10.43% | +23.51% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AFX Stock
- Company Carl Zeiss Meditec AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition